Related Experiment Videos
Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a
L Kanter-Lewensohn1, A Dricu, M Wang
1Cellular and Molecular Tumor Pathology, CCK, Karolinska Hospital, Stockholm, Sweden.
Abstract:
The insulin-like growth factor-1 receptor (IGF-1R) and its possible protective effect on apoptotic cell death in malignant melanoma was analysed in four commercial melanoma cell lines. Inhibition of N-linked glycosylation by tunicamycin, which has previously been shown to block the translocation of IGF-1R to the cell surface, blocked cell growth and/or induced cell death in these cell lines. Treatment with alphaIR-3, an antibody blocking the binding domain of IGF-1R, also resulted in growth arrest and/or apoptosis. We also analysed lymph node metastases of malignant melanoma by Western blotting and immunohistochemistry. All these cases were shown to express IGF-1R at the cell surface. In three cases of lymph node metastases we had access to both tumour specimens and cultured cells. One of these exhibited a substantially higher expression of IGF-1R than the two other cases. The corresponding cell lines showed growth arrest and apoptosis following treatment with alphaIR-3. However, the two cell lines with low expression of IGF-1R were more sensitive in this respect. Furthermore, we demonstrated an inverse correlation between IGF-1R expression and the frequency of apoptotic cells in the tumour specimens. Our data suggest that IGF-1R is crucial for the viability of malignant melanoma cells in vitro as well as in vivo.
Insights
The insulin-like growth factor-1 receptor (IGF-1R) is vital for malignant melanoma cell survival. Blocking IGF-1R function halts melanoma growth and induces cell death, highlighting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Malignant melanoma is a significant health concern.
- The role of insulin-like growth factor-1 receptor (IGF-1R) in melanoma progression is under investigation.
- Understanding IGF-1R's function is crucial for developing targeted therapies.
Purpose of the Study:
- To analyze the role of IGF-1R in malignant melanoma cell viability.
- To investigate the protective effect of IGF-1R against apoptotic cell death.
- To evaluate IGF-1R expression in melanoma metastases and its correlation with treatment response.
Main Methods:
- Utilized four commercial melanoma cell lines.
- Inhibited N-linked glycosylation using tunicamycin to affect IGF-1R translocation.
- Treated cells and tumor specimens with alphaIR-3, an IGF-1R blocking antibody.
- Performed Western blotting and immunohistochemistry on lymph node metastases.
Main Results:
- Tunicamycin treatment blocked cell growth and induced cell death in melanoma cell lines.
- AlphaIR-3 treatment resulted in growth arrest and apoptosis.
- IGF-1R was expressed on the cell surface of all analyzed lymph node metastases.
- An inverse correlation was observed between IGF-1R expression and the frequency of apoptotic cells in tumor specimens.
Conclusions:
- IGF-1R plays a critical role in maintaining the viability of malignant melanoma cells.
- Blocking IGF-1R function effectively inhibits melanoma cell growth and induces apoptosis.
- IGF-1R is a potential therapeutic target for malignant melanoma treatment.